ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,118,076 | -17.3% | 1,745,943 | 0.0% | 5.10% | +9.6% |
| Q2 2023 | $23,116,285 | -2.7% | 1,745,943 | 0.0% | 4.66% | -24.6% |
| Q1 2023 | $23,762,284 | -30.3% | 1,745,943 | 0.0% | 6.17% | -30.2% |
| Q4 2022 | $34,098,267 | +2.5% | 1,745,943 | 0.0% | 8.85% | +12.3% |
| Q3 2022 | $33,260,000 | -7.5% | 1,745,943 | 0.0% | 7.88% | -21.2% |
| Q2 2022 | $35,966,000 | -36.0% | 1,745,943 | 0.0% | 9.99% | -33.7% |
| Q1 2022 | $56,184,000 | -34.6% | 1,745,943 | -5.4% | 15.08% | -3.7% |
| Q4 2021 | $85,890,000 | +51.0% | 1,844,727 | -12.5% | 15.66% | +77.4% |
| Q3 2021 | $56,891,000 | -5.2% | 2,107,092 | -9.9% | 8.82% | -10.4% |
| Q2 2021 | $59,985,000 | -25.5% | 2,338,581 | -0.7% | 9.85% | -2.6% |
| Q1 2021 | $80,513,000 | -49.5% | 2,355,557 | -50.0% | 10.12% | -26.5% |
| Q4 2020 | $159,330,000 | +174.2% | 4,711,114 | +100.0% | 13.76% | -1.7% |
| Q3 2020 | $58,112,000 | – | 2,355,557 | – | 14.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |